Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $fdmt

$FDMT stock shows mixed sentiment with recent posts highlighting options trading and potential price movements. Investors are watching key clinical pipeline updates and institutional stake changes.

### About $fdmt
4D Molecular Therapeutics is a biotechnology company focused on developing gene therapies for various diseases.  

### Engagements: XX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$fdmt/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$fdmt/time-series/interactions.tsv)  
Current Value: XX  
Daily Average: XXXXX  
X Week: XXXXX -XX%  
X Month: XXXXXX -XX%  
X Months: XXXXXXX +57%  
X Year: XXXXXXXXX -XX%  
1-Year High: XXXXXXX on 2025-08-01  
1-Year Low: X on 2025-05-04  

Engagements by network (24h):
X: XX

  
  
### Mentions: X (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$fdmt/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$fdmt/time-series/posts_active.tsv)  
Current Value: X  
Daily Average: XX  
X Week: XXX -XX%  
X Month: XXXXX +343%  
X Months: XXXXX +510%  
X Year: XXXXX +27%  
1-Year High: XXX on 2025-08-04  
1-Year Low: X on 2025-04-26  

Mentions by network (24h):
X: XX

  
  
### Creators: X (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$fdmt/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$fdmt/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $fdmt in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XXX -XX%  
X Month: XXX +676%  
X Months: XXXXX +1,173%  
X Year: XXXXX +269%  
1-Year High: XXX on 2025-08-10  
1-Year Low: X on 2025-04-26  

The most influential creators that mention $fdmt in the last XX hours

| Creator                                          | Rank | Followers | Posts | Engagements |
| -------                                          | ---- | --------- | ----- | ----------- |
| [@LiquidThetr_1](/creator/twitter/LiquidThetr_1) | X    | XXX       | X     | XX          |

[View More](/list/creators/$fdmt/100)
  
  
### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$fdmt/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$fdmt/time-series/sentiment.tsv)  
Current Value: XXX%  
Daily Average: XX%  
X Week: XX% -XX%  
X Month: XX% -XX%  
X Months: XX% -XX%  
X Year: XX% -XX%  
1-Year High: XXX% on 2024-12-11  
1-Year Low: XX% on 2025-02-18  

Most Supportive Themes:
- Partnership with Otsuka Pharmaceuticals: (10%) 4D Molecular Therapeutics has entered into an agreement with Otsuka Pharmaceuticals for the Asia-Pacific rights to its 4D-150 asset, potentially worth over $XXX million.
- Advancing Clinical Pipeline: (15%) The company is progressing its clinical pipeline, with specific mention of 4D-150 for eye diseases and 4D-710 for cystic fibrosis, indicating ongoing development and potential future catalysts.
- Institutional Investment and Stake Increases: (20%) Significant investors like Novo Holdings and BVF Inc. have increased their stakes in 4D Molecular Therapeutics, signaling strong institutional confidence in the company's prospects.
  
Most Critical Themes:
- Concerns over Fabry Program: (5%) There are doubts expressed about the company's Fabry program, with a specific mention that Cantor Fitzgerald has difficulty seeing any effect from it, and that 4D Molecular Therapeutics may no longer be developing it.
  

### Top $fdmt Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$FDMT Share Price: $XXXXX Contract Selected: Jul XX 2026 $XX Calls Buy Zone: $XXXX $XXXX Target Zone: $XXXX $XXXX Potential Upside: XX% ROI Time to Expiration: XXX Days Click here to join๐Ÿ’Ž: Reply "stocks" to get started"  
[X Link](https://x.com/LiquidThetr_12/status/1998416671007277208) [@LiquidThetr_12](/creator/x/LiquidThetr_12) 2025-12-09T15:37Z XXX followers, X engagements


"๐Ÿ’Ž LiquidTheta Live Actionable Trade Asset: $FDMT Contracts: $FDMT July XX 2026 $XX Calls Scale in: $2.66- $XXXX Scale out: $10.33-$17.70 Profit Potential : XXX% ROI Blended Click here to Reply "1" to get started"  
[X Link](https://x.com/LiquidThetr_1/status/1996026231641550954) [@LiquidThetr_1](/creator/x/LiquidThetr_1) 2025-12-03T01:18Z XXX followers, XX engagements


"Nov 24-28 Stock Scan Highlights $UPB XXXXX - XXXX XX% $SONO XXXXX -XXXXX X% $ERO XXXXX - XXXXX XX% $IRWD XXXX - XXXX - XXX XX% - X% $FDMT XXXXX - XXXXX X% The performance of the indexes $SPY XXXXXX - XXXXXX X% $QQQ XXXXXX - XXXXXX 4%"  
[X Link](https://x.com/SwingTheBreak/status/1995108121333707059) [@SwingTheBreak](/creator/x/SwingTheBreak) 2025-11-30T12:30Z XX followers, XX engagements


"Mizuho Key opinion leaders express cautious optimism for Tinlarebant ahead of this week's Phase X data readout in Stargardt disease. Full report in Bio $BLTE $RETA $EYEN $OCUL $ADVM $RGNX $BEAM $NTLA $EDIT $CRSP $FDMT $RXRX $KYMR $IMGN $AGIO"  
[X Link](https://x.com/Biobeats99/status/1992988970779611377) [@Biobeats99](/creator/x/Biobeats99) 2025-11-24T16:09Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$fdmt

$FDMT stock shows mixed sentiment with recent posts highlighting options trading and potential price movements. Investors are watching key clinical pipeline updates and institutional stake changes.

About $fdmt

4D Molecular Therapeutics is a biotechnology company focused on developing gene therapies for various diseases.

Engagements: XX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -XX%
X Months: XXXXXXX +57%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-08-01
1-Year Low: X on 2025-05-04

Engagements by network (24h): X: XX

Mentions: X (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
X Week: XXX -XX%
X Month: XXXXX +343%
X Months: XXXXX +510%
X Year: XXXXX +27%
1-Year High: XXX on 2025-08-04
1-Year Low: X on 2025-04-26

Mentions by network (24h): X: XX

Creators: X (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $fdmt in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XXX -XX%
X Month: XXX +676%
X Months: XXXXX +1,173%
X Year: XXXXX +269%
1-Year High: XXX on 2025-08-10
1-Year Low: X on 2025-04-26

The most influential creators that mention $fdmt in the last XX hours

Creator Rank Followers Posts Engagements
@LiquidThetr_1 X XXX X XX

View More

Sentiment: XXX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2024-12-11
1-Year Low: XX% on 2025-02-18

Most Supportive Themes:

  • Partnership with Otsuka Pharmaceuticals: (10%) 4D Molecular Therapeutics has entered into an agreement with Otsuka Pharmaceuticals for the Asia-Pacific rights to its 4D-150 asset, potentially worth over $XXX million.
  • Advancing Clinical Pipeline: (15%) The company is progressing its clinical pipeline, with specific mention of 4D-150 for eye diseases and 4D-710 for cystic fibrosis, indicating ongoing development and potential future catalysts.
  • Institutional Investment and Stake Increases: (20%) Significant investors like Novo Holdings and BVF Inc. have increased their stakes in 4D Molecular Therapeutics, signaling strong institutional confidence in the company's prospects.

Most Critical Themes:

  • Concerns over Fabry Program: (5%) There are doubts expressed about the company's Fabry program, with a specific mention that Cantor Fitzgerald has difficulty seeing any effect from it, and that 4D Molecular Therapeutics may no longer be developing it.

Top $fdmt Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$FDMT Share Price: $XXXXX Contract Selected: Jul XX 2026 $XX Calls Buy Zone: $XXXX $XXXX Target Zone: $XXXX $XXXX Potential Upside: XX% ROI Time to Expiration: XXX Days Click here to join๐Ÿ’Ž: Reply "stocks" to get started"
X Link @LiquidThetr_12 2025-12-09T15:37Z XXX followers, X engagements

"๐Ÿ’Ž LiquidTheta Live Actionable Trade Asset: $FDMT Contracts: $FDMT July XX 2026 $XX Calls Scale in: $2.66- $XXXX Scale out: $10.33-$17.70 Profit Potential : XXX% ROI Blended Click here to Reply "1" to get started"
X Link @LiquidThetr_1 2025-12-03T01:18Z XXX followers, XX engagements

"Nov 24-28 Stock Scan Highlights $UPB XXXXX - XXXX XX% $SONO XXXXX -XXXXX X% $ERO XXXXX - XXXXX XX% $IRWD XXXX - XXXX - XXX XX% - X% $FDMT XXXXX - XXXXX X% The performance of the indexes $SPY XXXXXX - XXXXXX X% $QQQ XXXXXX - XXXXXX 4%"
X Link @SwingTheBreak 2025-11-30T12:30Z XX followers, XX engagements

"Mizuho Key opinion leaders express cautious optimism for Tinlarebant ahead of this week's Phase X data readout in Stargardt disease. Full report in Bio $BLTE $RETA $EYEN $OCUL $ADVM $RGNX $BEAM $NTLA $EDIT $CRSP $FDMT $RXRX $KYMR $IMGN $AGIO"
X Link @Biobeats99 2025-11-24T16:09Z XXX followers, XXX engagements

$fdmt
/topic/$fdmt